ClinicalTrials.Veeva

Menu

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

Johnson & Johnson (J&J) logo

Johnson & Johnson (J&J)

Status

Terminated

Conditions

Myopia
Refractive Error
Astigmatism

Treatments

Device: senofilcon A sphere soft contact lens
Device: senofilcon A toric soft contact lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT00639353
CR-0804

Details and patient eligibility

About

This study seeks to evaluate the clinical performance of a recently released contact lens designed to correct astigmatism to an established contact lens that has historically been used in these patients.

Enrollment

102 patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The subject is 18 to 39 years of age. (Parental consent is required for a minor child i.e. under the age of 20.)
  2. The subject has signed an informed consent with his/her own judgement for participation in the study.
  3. The subject currently is a habitual wearer of spherical or toric daily-wear soft contact lenses, excluding daily disposables, in daily wear bases.

Exclusion criteria

  1. The subject has any ocular or systemic allergies that interfere with contact lens wear.
  2. The subject has dry eye and lacrimal apparatus disease that could interfere with contact lens wear.
  3. The subject has any systemic disease or autoimmune disease that interferes with contact lens wear.
  4. The subject has corneal edema, neovascularization, corneal staining or other ocular abnormalities (Grade 3 or above) that clinically apparently interfere with contact lens wear.
  5. The subject has any anterior segment eye disease (palpebral abnormalities, corneal hypesthesia, corneal epithelial defect, bulbar conjunctival hyperemia, etc.) that clinically apparently interferes with contact lens wear.
  6. The subject has a history of solution reactions to the chemical cleaner/disinfectant to be used in this study, as far as known to the subject.
  7. The subject has ocular infection.
  8. The subject has ocular inflammation (including acute/subacute anterior segment inflammations and uveitis).
  9. The subject has corneal distortion resulting from previous experience of hard contact lens wear.
  10. The subject has infectious disease (pneumonia, tuberculosis, etc.) or immunosuppressive disease (HIV positive etc.), as far as known to the subject.
  11. The subject has diabetes, as far as known to the subject.
  12. The subject is pregnant or in the lactation period, as far as known to the subject.
  13. The subject uses any eye remedies (excluding artificial tear substitutes or hyaluronic acid drops for reducing dryness while wearing contact lenses).
  14. The subject had any ocular trauma or surgery within 8 weeks prior to participation in the study.
  15. The subject is a wearer of hard contact lenses (including rigid gas permeable).
  16. The subject is exposed to a dry environment on a constant basis.
  17. The subject is exposed to a living environment where dust, chemicals, etc. can easily enter the eye.
  18. The subject is unable to follow the principal investigator's instructions.
  19. The subject is unable to follow lens hygiene procedures necessary for contact lens wear.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

102 participants in 2 patient groups

spherical contact lens
Active Comparator group
Description:
Subjects will wear and evaluate a spherical soft contact lens daily for 2 weeks
Treatment:
Device: senofilcon A sphere soft contact lens
toric contact lens
Experimental group
Description:
Subjects will wear and evaluate a toric soft contact lens daily for 2 weeks
Treatment:
Device: senofilcon A toric soft contact lens

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems